Walleye Trading’s Immunic IMUX Stock Holding History

Walleye Trading’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-76	Closed	-$8K	–	4949
2018 Q3	$8K	Buy	+76	New	+$198K	﹤0.01%	5029
2016 Q3	–	Sell	-2	Closed	-$4K	–	5094
2016 Q2	$4K	Buy	+2	New	+$6.57K	﹤0.01%	5031

Other funds holding IMUX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Walleye Trading's IMUX Position: Q3 2016 in Review

Walleye Trading sold out of Immunic (IMUX) in Q3 2016, closing a stake of 1 share — an estimated $3K sold.

Walleye Trading first reported a position in IMUX in Q3 2015 and held it in 2 quarters. The position peaked at $12K in Q3 2015. 51 funds tracked by Wall St. Rank hold IMUX as of Q3 2016.

Walleye Trading reported no remaining Immunic position as of Q3 2016 after selling out during the quarter.
Walleye Trading sold 1 Immunic share in Q3 2016, an estimated $3K.
Walleye Trading first reported a position in Immunic in Q3 2015 and held it in 2 quarters.
Walleye Trading's Immunic position peaked at $12K in Q3 2015.
51 funds tracked by Wall St. Rank held Immunic as of Q3 2016.

Based on Walleye Trading's 13F filing for Q3 2016, filed 14 Nov 2016.